30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

David Drutz

Insider profile

Currently holds a position at Altimmune Inc

Performance

Overall performance
3.0

Performance over holding periods
4.2
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 32% 68% 82%
Transactions
6 67% Buy
34 71% Buy
47 69% Buy

Performance for realised trades
4.4
Average return 51%
Success rate 73%
Average holding period 220
Transactions 28

Positions

Position Company Period
Independent Director Altimmune Inc Jan. 1, 2018 -
Chairman of the Board Altimmune Inc May 4, 2017 - Jan. 1, 2018
Independent Director Mirati Therapeutics Inc Jan. 1, 2000 - June 27, 2012

David Drutz's trades of Altimmune Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-08-20 2024-08-19 S Sale
94,901 +3.1%
301.13
US$3,506,591
94,901 +3.1% 301.13 US$3,506,591
2024-08-20 2024-08-19 S Sale
33,481 -30.0%
407.35
US$1,939,371
33,481 -30.0% 407.35 US$1,939,371
2023-08-15 2023-08-15 B Purchase
52,531 +3.4%
415.89
US$3,345,244
52,531 +3.4% 415.89 US$3,345,244
2023-03-27 2023-03-23 B Purchase
9,000 +43.9%
4.27
US$38,430
9,000 +43.9% 4.27 US$38,430
2022-06-16 2022-06-15 B Purchase
1,000 +5.3%
8.00
US$8,000
1,000 +5.3% 8.00 US$8,000
2022-05-25 2022-05-24 B Purchase
1,200 +6.7%
4.50
US$5,400
1,200 +6.7% 4.50 US$5,400